Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT02685267
Title Docetaxel/Prednisone Versus Docetaxel/Prednisone and Enzalutamide in Castration-Resistant Prostate Cancer (Doce/Enza)
Acronym Doce/Enza
Recruitment Terminated
Gender male
Phase Phase II
Variant Requirements No
Sponsors Prostate Cancer Clinical Trials Consortium
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
The University of Chicago Chicago Illinois 60637 United States Details
Decatur Memorial Hospital Decatur Illinois 62526 United States Details
NorthShore University HealthSytem - Kellogg Cancer Center Evanston Illinois 60201 United States Details
Roswell Park Cancer Institute Buffalo New York 14263 United States Details
Univesity of Wisconsin Madison Wisconsin 53705 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field